本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

75.39
+1.802.45%
盤後75.390.00000.00%16:46 EDT
成交量:58.60萬
成交額:4,400.86萬
市值:17.32億
市盈率:16.61
高:75.67
開:73.68
低:73.54
收:73.59
52周最高:98.55
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:1.58
換手率:2.89%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.90
市盈率(LYR):22.71

資料載入中...

2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities